• Peace of mind for the concerned consumer

    Anatara plans to develop Detach® for use in farmed animals, providing an alternative to the use of antibiotics and thereby helping farmers supply antibiotic free meat.

  • Natural treatment for animal health

    Anatara’s Detach® is a proven natural non-antibiotic treatment for diarrhoea in piglets with the potential for use in other farm livestock. More »

  • Advancing gastrointestinal health naturally

    Our product is made using an extract from pineapple stems that blocks the causes of diarrhoea. It’s a natural product that won’t contribute to the rise of so-called “superbugs” caused by the overuse of antibiotics.

  • Exclusive Global License Agreement with Zoetis

    Anatara has signed an exclusive licensing agreement with Zoetis Inc., the leading global animal health company, for the worldwide development, manufacture, distribution and marketing of Detach®. More >>

Company description

Anatara Lifesciences is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Our lead product Detach® is a natural product that will help address global concerns around the overuse of antibiotics in animals and their feed that is contributing to the rise of so-called “super bugs” that make infectious diseases harder to treat. The Anatara team has a strong track record in biological science as well as building and growing international biotech companies.

Video overview

Latest news All news

  • Change of Director’s Interest Notice

    Anatara Lifesciences have issued an Appendix 3Y notifying the market of a change in Director’s interest for Dr Jay Hetzel.

    Please click here to view the ASX announcement.

  • Anatara CEO Dr Mel Bridges announces retirement

    Anatara Lifesciences Ltd (ASX: ANR) announces that Executive Chairman, Dr Mel Bridges has informed the Board of his wish to retire from his role at Anatara with immediate effect and the Board has formally accepted his resignation.

    Please click here for the ASX announcement.


Investors Home